company background image
CSBR logo

Champions Oncology NasdaqCM:CSBR Stock Report

Last Price

US$4.94

Market Cap

US$67.2m

7D

-10.2%

1Y

18.2%

Updated

27 Mar, 2024

Data

Company Financials +

Champions Oncology, Inc.

NasdaqCM:CSBR Stock Report

Market Cap: US$67.2m

CSBR Stock Overview

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.

CSBR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Champions Oncology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Champions Oncology
Historical stock prices
Current Share PriceUS$4.94
52 Week HighUS$7.32
52 Week LowUS$4.02
Beta0.40
1 Month Change-16.97%
3 Month Change-8.69%
1 Year Change18.18%
3 Year Change-56.28%
5 Year Change-46.71%
Change since IPO-58.83%

Recent News & Updates

Recent updates

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M

Jul 21

We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

Oct 14
We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Jun 21
We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Apr 09
Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Mar 02
The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Feb 04
Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Jan 14
Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Dec 19
Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Dec 16
Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Champions Oncology beats on revenue

Dec 14

Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Dec 04
Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Shareholder Returns

CSBRUS Life SciencesUS Market
7D-10.2%-0.2%0.4%
1Y18.2%4.5%28.8%

Return vs Industry: CSBR exceeded the US Life Sciences industry which returned 3.9% over the past year.

Return vs Market: CSBR underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is CSBR's price volatile compared to industry and market?
CSBR volatility
CSBR Average Weekly Movement7.2%
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: CSBR's share price has been volatile over the past 3 months.

Volatility Over Time: CSBR's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985230Ronnie Morrishttps://www.championsoncology.com

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Champions Oncology, Inc. Fundamentals Summary

How do Champions Oncology's earnings and revenue compare to its market cap?
CSBR fundamental statistics
Market capUS$67.15m
Earnings (TTM)-US$9.73m
Revenue (TTM)US$49.22m

1.4x

P/S Ratio

-6.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CSBR income statement (TTM)
RevenueUS$49.22m
Cost of RevenueUS$29.49m
Gross ProfitUS$19.74m
Other ExpensesUS$29.46m
Earnings-US$9.73m

Last Reported Earnings

Jan 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.72
Gross Margin40.09%
Net Profit Margin-19.76%
Debt/Equity Ratio0%

How did CSBR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.